Trexquant Investment LP Purchases New Position in Cardiovascular Systems, Inc. (CSII)

Trexquant Investment LP purchased a new position in shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 9,800 shares of the medical device company’s stock, valued at approximately $276,000.

Several other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in shares of Cardiovascular Systems by 12.6% during the 2nd quarter. Vanguard Group Inc. now owns 1,864,604 shares of the medical device company’s stock worth $60,096,000 after acquiring an additional 208,248 shares during the period. Cortina Asset Management LLC lifted its holdings in Cardiovascular Systems by 5.0% during the 3rd quarter. Cortina Asset Management LLC now owns 872,363 shares of the medical device company’s stock worth $24,557,000 after purchasing an additional 41,496 shares in the last quarter. State Street Corp lifted its holdings in Cardiovascular Systems by 0.9% during the 2nd quarter. State Street Corp now owns 677,462 shares of the medical device company’s stock worth $21,828,000 after purchasing an additional 6,074 shares in the last quarter. New York State Common Retirement Fund lifted its holdings in Cardiovascular Systems by 4.9% during the 3rd quarter. New York State Common Retirement Fund now owns 464,811 shares of the medical device company’s stock worth $13,084,000 after purchasing an additional 21,507 shares in the last quarter. Finally, Northern Trust Corp lifted its holdings in Cardiovascular Systems by 4.9% during the 2nd quarter. Northern Trust Corp now owns 441,314 shares of the medical device company’s stock worth $14,224,000 after purchasing an additional 20,434 shares in the last quarter. Institutional investors own 75.05% of the company’s stock.

CSII has been the topic of a number of recent research reports. Zacks Investment Research raised Cardiovascular Systems from a “sell” rating to a “hold” rating in a report on Monday, November 13th. Citigroup initiated coverage on Cardiovascular Systems in a report on Thursday, September 21st. They set a “market perform” rating on the stock. Raymond James Financial initiated coverage on Cardiovascular Systems in a report on Friday, September 22nd. They set a “market perform” rating on the stock. Needham & Company LLC reissued a “buy” rating and set a $37.00 price objective on shares of Cardiovascular Systems in a report on Thursday, October 12th. Finally, BidaskClub cut Cardiovascular Systems from a “sell” rating to a “strong sell” rating in a report on Friday, August 18th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. Cardiovascular Systems has an average rating of “Hold” and an average price target of $38.00.

Shares of Cardiovascular Systems, Inc. (CSII) opened at $23.93 on Thursday. The stock has a market capitalization of $811.07, a PE ratio of 1,188.50 and a beta of 2.52. The company has a debt-to-equity ratio of 0.18, a quick ratio of 3.83 and a current ratio of 4.30. Cardiovascular Systems, Inc. has a 1-year low of $23.00 and a 1-year high of $33.11.

Cardiovascular Systems (NASDAQ:CSII) last issued its quarterly earnings data on Wednesday, October 25th. The medical device company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.02. The business had revenue of $49.70 million for the quarter, compared to analysts’ expectations of $51.00 million. Cardiovascular Systems had a positive return on equity of 0.74% and a negative net margin of 0.93%. The firm’s quarterly revenue was down .2% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.06) EPS. analysts expect that Cardiovascular Systems, Inc. will post -0.05 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Trexquant Investment LP Purchases New Position in Cardiovascular Systems, Inc. (CSII)” was reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.chaffeybreeze.com/2017/12/07/trexquant-investment-lp-purchases-new-position-in-cardiovascular-systems-inc-csii.html.

About Cardiovascular Systems

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems, Inc. (NASDAQ:CSII).

Institutional Ownership by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply